Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension

被引:27
|
作者
Pankey, Edward A. [1 ]
Badejo, Adeleke M. [1 ]
Casey, David B. [1 ]
Lasker, George F. [1 ]
Riehl, Russel A. [1 ]
Murthy, Subramanyam N. [1 ]
Nossaman, Bobby D. [1 ,2 ]
Kadowitz, Philip J. [1 ]
机构
[1] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA
[2] Ochsner Med Ctr, Crit Care Med Sect, Dept Anesthesiol, New Orleans, LA 70121 USA
来源
NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 2012年 / 27卷 / 01期
关键词
Pulmonary vascular bed; Pulmonary hypertension/therapy; Right ventricular hypertrophy; Sodium nitrite; Nitric oxide; Monocrotaline; MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; VASCULAR SMOOTH-MUSCLE; ARTERIAL-HYPERTENSION; GUANYLATE-CYCLASE; XANTHINE OXIDOREDUCTASE; VASODILATOR RESPONSES; GLYCERYL TRINITRATE; OXIDE SYNTHASE; DEPENDENT VASODILATION; SIGNALING MOLECULE;
D O I
10.1016/j.niox.2012.02.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pulmonary hypertension (PH) is a rare disorder that without treatment is progressive and often fatal within 3 years. The treatment of PH involves the use of a diverse group of drugs and lung transplantation. Although nitrite was once thought to be an inactive metabolite of endothelial-derived nitric oxide (NO), there is increasing evidence that nitrite may be useful in the treatment of PH, but the mechanism by which nitrite exerts its beneficial effect remains uncertain. The purpose of this study was to investigate the effect of chronic sodium nitrite treatment in a PH model in the rat. Following induction of PH with a single injection of monocrotaline, 60 mg: daily ip injections of sodium nitrite (3 mg/kg) starting on day 14 and continuing for 21 days, resulted in a significantly lower pulmonary arterial pressure on day 35 when compared to values in untreated animals with monocrotaline-induced PH. In monocrotaline-treated rats, daily treatment with ip nitrite injections for 21 days decreased right ventricular mass and pathologic changes in small pulmonary arteries. Nitrite therapy did not change systemic arterial pressure or cardiac output when values were measured on day 35. The decreases in pulmonary arterial pressure in response to iv injections of sodium nitroprusside, sodium nitrite, and BAY 41-8543 were not different in rats with monocrotaline-induced pulmonary hypertension and rats with chronic nitrite therapy when compared to responses in animals in which pulmonary arterial pressure was increased with U46619. These findings are consistent with the hypothesis that the mechanisms that convert nitrite to vasoactive NO, activate soluble guanylyl cyclase and mediate the vasodilator response to NO or an NO derivative are not impaired. The present data are consistent with the results of a previous study in monocrotaline-induced PH in which systemic arterial pressure and cardiac output were not evaluated and are consistent with the hypothesis that nitrite is effective in the treatment of monocrotaline-induced PH in the rodent. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [1] The effect of atorvastatin on monocrotaline-induced pulmonary hypertension
    Xie, H.
    Xie, L. D.
    Xu, C. S.
    EUROPEAN HEART JOURNAL, 2006, 27 : 832 - 833
  • [2] Effect of thrombomodulin on the development of monocrotaline-induced pulmonary hypertension
    Yamada, Yasuharu
    Maruyama, Junko
    Zhang, Erquan
    Okada, Amphone
    Yokochi, Ayumu
    Sawada, Hirofumi
    Mitani, Yoshihide
    Hayashi, Tatsuya
    Suzuki, Koji
    Maruyama, Kazuo
    JOURNAL OF ANESTHESIA, 2014, 28 (01) : 26 - 33
  • [3] Effect of thrombomodulin on the development of monocrotaline-induced pulmonary hypertension
    Yasuharu Yamada
    Junko Maruyama
    Erquan Zhang
    Amphone Okada
    Ayumu Yokochi
    Hirofumi Sawada
    Yoshihide Mitani
    Tatsuya Hayashi
    Koji Suzuki
    Kazuo Maruyama
    Journal of Anesthesia, 2014, 28 : 26 - 33
  • [4] EFFECTS OF NITRATE THERAPY IN MONOCROTALINE-INDUCED PULMONARY HYPERTENSION IN RATS
    Kmecova, Z.
    Malikova, E.
    Krenek, P.
    Klimas, J.
    JOURNAL OF HYPERTENSION, 2017, 35 : E278 - E278
  • [5] Effect of chronic administration of aminoguanidine on the reactivity of pulmonary vessels in rats with monocrotaline-induced pulmonary hypertension
    Bonartsev, A
    Slavutskaja, A
    Postnikov, A
    Medvedeva, N
    JOURNAL OF HYPERTENSION, 2004, 22 : S30 - S30
  • [6] Nebivolol has a beneficial effect in monocrotaline-induced pulmonary hypertension
    Pankey, Edward A.
    Edward, Justin A.
    Swan, Kevin W.
    Bourgeois, Camille R. T.
    Bartow, Matthew J.
    Yoo, Daniel
    Peak, Taylor A.
    Song, Bryant M.
    Chan, Ryan A.
    Murthy, Subramanyam N.
    Prieto, Minolfa C.
    Giles, Thomas D.
    Kadowitz, Philip J.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2016, 94 (07) : 758 - 768
  • [7] The Beneficial Effect of Suramin on Monocrotaline-Induced Pulmonary Hypertension in Rats
    Izikki, Mohamed
    Mercier, Olaf
    Lecerf, Florence
    Guin, Lauriane Lubert
    Hoang, Eric
    Dorfmueller, Peter
    Perros, Frederic
    Humbert, Marc
    Simonneau, Gerald
    Dartevelle, Philippe
    Fadel, Elie
    Eddahibi, Saadia
    PLOS ONE, 2013, 8 (10):
  • [8] The effect and mechanism of felodipine on monocrotaline-induced pulmonary hypertension in rats
    Zeng, ZY
    Huang, H
    Li, XS
    HYPERTENSION, 2002, 40 (03) : 438 - 438
  • [9] Progesterone attenuates monocrotaline-induced pulmonary hypertension
    Tofovic, SP
    Zhang, XC
    FASEB JOURNAL, 2005, 19 (05): : A1333 - A1333
  • [10] Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension
    Fontoura, Duice
    Oliveira-Pinto, Jose
    Tavares-Silva, Marta
    Leite, Sara
    Vasques-Novoa, Francisco
    Mendes-Ferreira, Pedro
    Lourenco, Andre P.
    Leite-Moreira, Adelino F.
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2014, 33 (04) : 213 - 222